The global biologics contract manufacturing market is expected to approach US$ 29.3 billion by 2030, with an annual growth rate of more than 9.5%
Wilmington, Delaware, Oct. 13, 2023 (GLOBE NEWSWIRE) — Global Biologics Contract Manufacturing Market value is estimated at US$ 15.5 billion in 2023 and is expected to grow at a significant CAGR of over 9.5% over the forecast period of 2023-2030, according to the latest market report by RationalStat
Market Definition, Market Scope, and Report Overview
Biologics contract manufacturing refers to the outsourcing of biopharmaceutical product manufacture and manufacturing to specialized contract manufacturing organizations (CMOs), which includes vaccines, monoclonal antibodies, gene treatments, and other complicated biological medications.
Because of their effectiveness in treating diseases such as cancer, autoimmune disorders, and genetic abnormalities, the global demand for biopharmaceuticals such as monoclonal antibodies, vaccines, and gene treatments is continuously expanding. This rising demand increases the requirement for efficient and dependable biologics contract manufacturing services.
- According to a deep-dive market assessment by RationalStat, the global Biologics Contract Manufacturing market has been analyzed on the basis of market segments, including product, indication, service type and geography/regions (including North America, Latin America, Western Europe, Eastern Europe, Middle East & Africa, and Asia Pacific). The report also offers global and regional market sizing for the historical period of 2019-2022 and the forecast period of 2023-2030.
- Market intelligence for the global Biologics Contract Manufacturing market covers market sizes on the basis of market value (US$/EUR Million) and volume (Units) by various products/services/equipment, demand assessment across the key regions, customer sentiments, price points, cost structures, margin analysis across the value chain, financial assessments, historical and forecast data, key developments across the industry, import-export data, trade overview, components market by leading companies, etc.
- In addition, the long-term sector and products/services 10-year outlook and its implications on the global Biologics Contract Manufacturing market. It also includes the industry’s current state – Production Levels, Capacity Utilization, Tech quotient, etc. Key information will be manufacturing capacity by country, installed base, import volumes, market size, key players, market size, dynamics, market data, insights, etc.
Request A Customization- https://store.rationalstat.com/store/global-biologics-contract-manufacturing-market/#tab-ux_global_tab
Global Biologics Contract Manufacturing Market: Segmental and Market Share Analysis
- On the basis of indication, oncology segment is anticipated to dominate the global Biologics contract manufacturing market with 48% market share. It is estimated to remain dominant during the forecast period.
- On the basis of product, MABs segment was dominated the market in 2022 owing to the extensive usage of the products made by MABs.
Report Synopsis
| Report Metrics | Details |
| Base Year | 2023 |
| Forecast Period | 2023-2030 |
| Base Year Market Size | US$ 15.5 billion |
| Market Size Forecast | US$ 29.3 billion |
| Growth Rate | 9.5% |
| Key Market Drivers |
|
| Companies Profiled |
|
Explore more about this report- https://store.rationalstat.com/store/global-biologics-contract-manufacturing-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Players engaged in this market adopt various strategies in order to reinforce their market share and gain a competitive edge over other competitors in the market. Mergers & acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global biologics contract manufacturing market include,
- In August 2021, Catalent, Inc. acquired RheinCell Therapeutics GmbH, a developer and manufacturer of GMP-grade human induced pluripotent stem cells (iPSCs).
Some of the prominent players and suppliers operating and contributing significantly to the global biologics contract manufacturing market growth include Wuxi Biologics, Abzena Ltd., Lonza, Abbvie, Catalent, Eurofins CDMO, Thermo Fisher Scientific Inc., Bioreliance, SansungBiologics, Boehringer Ingelheim GmbH, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., and BioXcellence, AGC Biologics, among others.
Get A Free Sample- https://store.rationalstat.com/store/global-biologics-contract-manufacturing-market/#tab-ux_global_tab
RationalStat has segmented the global biologics contract manufacturing market based on product, indication, service type, and region
- Global Biologics Contract Manufacturing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Product
- MABs
- Recombinant Protein
- Others
- Global Biologics Contract Manufacturing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Indication
- Oncology
- Hematology Disorders
- Cardiovascular Disorders (CVDs)
- Immunological Disorders
- Global Biologics Contract Manufacturing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Service Type
- Clinical Services
- Commercial Services
- Global Biologics Contract Manufacturing Market Value (US$ Million), Volume (Units), and Market Share (2019-2030) Analysis by Region
- North America Biologics Contract ManufacturingMarket
- US
- Canada
- Latin America Biologics Contract ManufacturingMarket
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Biologics Contract ManufacturingMarket
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Biologics Contract ManufacturingMarket
- Russia
- Poland
- Hungary
- Other CIS Countries
- Rest of Eastern Europe
- Asia Pacific Biologics Contract ManufacturingMarket
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- Philippines
- Vietnam
- Malaysia
- Rest of ASEAN
- Rest of Asia Pacific
- Middle East & Africa Biologics Contract ManufacturingMarket
- GCC
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Rest of the GCC
- South Africa
- Nigeria
- Turkey
- Rest of the Middle East & Africa
- GCC
- North America Biologics Contract ManufacturingMarket
For more information about this report- https://store.rationalstat.com/store/global-biologics-contract-manufacturing-market/#tab-ux_global_tab
Key Questions Answered in the Biologics Contract Manufacturing Report:
- What will be the market value of the global biologics contract manufacturing market by 2030?
- What is the market size of the global biologics contract manufacturing market?
- What are the market drivers of the global biologics contract manufacturing market?
- What are the key trends in the global biologics contract manufacturing market?
- Which is the leading region in the global biologics contract manufacturing market?
- What are the major companies operating in the global Biologics Contract Manufacturing market?
- What are the market shares by key segments in the global biologics contract manufacturing market?
Running a year End discount of 20%-https://store.rationalstat.com/store/global-biologics-contract-manufacturing-market/#tab-ux_global_tab
Explore Our Trending Reports
- Global Hormone Replacement Therapy Market– The Global Hormone Replacement Therapy Market is expected to grow at a CAGR of 5.1% over the forecast period of 2022-2028.
- Global Animal Model Market Analysis and Trends– The Global Animal Model Market is expected to grow at a CAGR of 6.1% over the forecast period of 2022-2028.
- Global Hard Gelatin Capsules Market Analysis and Forecast– The pharmaceutical industry is witnessing significant growth globally, driven by factors such as rising healthcare expenditure, increasing prevalence of chronic diseases, and advancements in drug development.
- Global Analgesics Market – The Global Analgesics Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028.
- Global Over-the-Counter (OTC) Drugs Market– The global Over the Counter Drugs Market is expected to grow at a CAGR of 6.6% over the forecast period of 2022-2028.
- Global Mental Health Software Market– The global mental health software market was US$ 4.5 Bn in 2021 and is expected to grow at a significant pace of 11.5% over the forecast period.
- Global advanced wound care market– The global advanced wound care market was valued at US$ 9.87 billion in 2022 and is expected to grow at a CAGR of 6.2% from 2023 to 2028.
- Global Dental Implant Market– The global dental implant market is projected to expand at a CAGR of 9% during the forecast period. Increasing applications of dental implants in various therapeutic areas, as well as rising demand for prosthetics, are among the key factors anticipated to drive den tal implant market expansion.
- Global Anti-Aging Market– The global Anti-Aging market was US$ 55.0 Bn in 2022 and is estimated to reach over US$ 88.0 Bn by 2028, growing at a CAGR of 6.9% over the forecast period of 2023-2028.
- Global Cartilage Repair and Cartilage Regeneration Market– The global Cartilage Repair and Cartilage Regeneration Market is expected to grow at a CAGR of 8% over the forecast period of 2022-2028.Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecasts, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Download Key Insights and Market Data – Raise a Query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company that provides comprehensive market research reports, customized strategy, and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client’s needs. Additional services offered by the company include consumer research, country reports, risk reports, valuations and advisory, financial research, due diligence, procurement and supply chain research, data analytics, and analytical dashboards.
Contact
RationalStat LLC
Kimberly Shaw,
Content and Press Manager
sales@rationalstat.com
US Phone: +1 302 803 5429
UK Phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | Pinterest
- Columbus Circle Capital Corp I Announces Pricing of Upsized $220,000,000 Initial Public Offering - May 15, 2025
- 2025 Ontario Budget Affirms Province’s Promise to Build Homes Faster and Improve Affordability - May 15, 2025
- Machine Learning Engineer Roadmap For Google Amazon Facebook Netflix Microsoft – Best Machine Learning Interview Preparation Course 2025 - May 15, 2025
